Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice-Reference-Cited by-同舟云学术

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice

Published:2021 Issue: Volume:62 Page:100070
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

van Eenige Robin^ORCID,Ying Zhixiong,Tambyrajah Lauren,Pronk Amanda C.M.,Blomberg Niek,Giera Martin,Wang Yanan^ORCID,Coskun Tamer,van der Stelt Mario,Rensen Patrick C.N.,Kooijman Sander

Funder

Netherlands Heart Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference44 articles.

1. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis;van Diepen;Atherosclerosis,2013

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel;Boren;Eur. Heart J.,2020

3. Brown adipose tissue: function and physiological significance;Cannon;Physiol. Rev.,2004

4. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes;Himms-Hagen;Am. J. Physiol. Cell Physiol,2000

5. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development;Berbee;Nat. Commun.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting the role of cannabinoids in vascular health and disease;Journal of Cellular Physiology;2024-07-10

2. Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide;European Journal of Clinical Investigation;2023-12-09

3. Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury;Journal of Pharmacology and Experimental Therapeutics;2023-09-22

4. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice;eBioMedicine;2023-07

5. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice;Atherosclerosis;2023-05